Sorry, your browser doesn't support embedded videos.

Issue 62 • February 2026

Baby blues

Infant formula again under scrutiny

Briefing

Kraft Heinz rethinks split

Feature

Cultivated meat’s correction

Interview

Ice-cream firm Glacier talks strategy

Feature

Dairy milks GLP-1 rise

Thematic Take

Cloud in pharma

In association with

02/27/2026 11:11:44
  • Home | Baby blues
  • Editor's letter
  • Contents
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • In Depth
  • Safety spotlight returns to infant formula
  • New reality: cultivated meat recalibrates as funding pool shrinks
  • Ice-cream major Glacier talks M&A strategy
  • New US dietary guidelines puts industry on notice
  • GLP-1 drugs give dairy shot in the arm
  • The promise of cocoa-free chocolate
  • Events
  • Next issue
02/27/2026 00:00:00